Oventus Medical Limited Capital raise
Oventus Medical (ASX: OVN) is an Australian medical device company and global leader in the treatment of snoring and obstructive sleep apnoea.
McCullough Robertson advised Oventus on its $9 million capital raise, which the company will use to commercialise its suite of oral appliances – completing clinical trials, research and development and regulatory approvals for the current products in development.
In 2016 our team advised Oventus on its $12 million IPO. Oventus recently signed a manufacturing agreement with Hong Kong based Modern Dental Group and McCullough Robertson continues to support the company as it expands its international footprint.
To find out more, contact Reece Walker.